Supporters of psychedelic therapy hoped that MDMA would make history as the first illegal psychedelic to win FDA approval, paving the way for similar drugs to enter the medical mainstream.

Supporters of psychedelic therapy hoped that MDMA would make history as the first illegal psychedelic to win FDA approval, paving the way for similar drugs to enter the medical mainstream.

FDA Rejects MDMA Treatment for PTSD; Setbacks and New Directions by: Madeline Campbell of Womble Bond Dickinson (US) LLP - Law Meets Science Tuesday, September 10, 2024 ...

Despite the FDA's rejection of MDMA-assisted therapy, Lykos Therapeutics plans to push ahead for approval, despite internal turmoil and layoffs of 75% of company staff.

In June 2024, an FDA advisory committee voted overwhelmingly against the idea that the relevant clinical trials had proved the efficacy of MDMA for the treatment of PTSD.

The FDA granted “breakthrough therapy” status to MDMA-assisted therapy in 2017, which sped along its development and review. PTSD affects between 9 million to 13 million people annually in the U.S., ...

In June 2024, an FDA advisory committee voted overwhelmingly against the idea that the relevant clinical trials had proved the efficacy of MDMA for the treatment of PTSD.

FDA rejects psychedelic MDMA as treatment for PTSD, calling for additional study by: MATTHEW PERRONE AP Health Writer Posted: Aug 12, 2024 / 04:22 PM EDT Updated: Aug 14, 2024 / 03:39 PM EDT ...

“This is due in part to the fact that the FDA has not approved any new treatments for PTSD in nearly 25 years. This astounding lack of innovation has undoubtedly contributed to our rising ...

"FDA rejects Lykos Therapeutics' MDMA drug therapy for PTSD, requesting additional clinical trial. Concerns raised over safety and efficacy. Company plans to re ...

FDA rejects psychedelic MDMA as treatment for PTSD, calling for additional study By MATTHEW PERRONE AP Health Writer Aug 11, 2024 Updated Sep 1, 2024 0 ...